Table 1.
Participant characteristics stratified by HIV infection.
| Overall HCV GT1a (n=50) | HIV uninfected (n=26) | HIV infected (n=24) | |
|---|---|---|---|
| Sex, n (%) | |||
| Female | 11 (22%) | 11 (42%) | 0 (0%) |
| Male | 39 (78%) | 15 (58%) | 24 (100%) |
| Age (yrs), mean/SD | 34 (9) | 31 (10) | 38 (7) |
| Mode of HCV acquisition, n (%) | |||
| IDU | 34 (68%) | 20 (77%) | 14 (58%) |
| Sexual transmission | 11 (22%) | 2 (8%) | 9 (38%) |
| Other | 5 (10%) | 4 (15%) | 1 (4%) |
| IL28B genotype (rs12979860) | |||
| TT | 1 (2%) | 1 (4%) | 0 (0%) |
| CT | 23 (46%) | 13 (50%) | 10 (42%) |
| CC | 25 (50%) | 12 (46%) | 13 (54%) |
| Estimated duration of infection | |||
| Weeks, mean/SD | 29 (19) | 35 (19) | 23 (18) |
| <26weeks | 29 (58%) | 13 (50%) | 16 (67%) |
| ≥26 weeks | 21 (42%) | 13 (50%) | 8 (33%) |
| Median HCV RNA (log IU/mL)*, 25%, 75% | 5.3 (3.9, 6.1) | 5.3 (4.0, 5.9) | 5.3 (3.9, 6.4) |